(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 8018.77 | 8102.08 | -1.03 | 8018.77 | 8102.08 | -1.03 | 34739.60 | 30301.63 | 14.65 |
| Other Income | 137.84 | 131.52 | 4.81 | 137.84 | 131.52 | 4.81 | 498.03 | 406.80 | 22.43 |
| PBIDT | 1452.39 | 1567.87 | -7.37 | 1452.39 | 1567.87 | -7.37 | 7738.85 | 6054.84 | 27.81 |
| Interest | 96.14 | 136.73 | -29.69 | 96.14 | 136.73 | -29.69 | 614.38 | 627.80 | -2.14 |
| PBDT | 1356.25 | 1309.54 | 3.57 | 1356.25 | 1309.54 | 3.57 | 7002.87 | 5734.54 | 22.12 |
| Depreciation | 390.61 | 395.07 | -1.13 | 390.61 | 395.07 | -1.13 | 1644.73 | 1462.30 | 12.48 |
| PBT | 965.64 | 914.47 | 5.60 | 965.64 | 914.47 | 5.60 | 5358.14 | 4272.24 | 25.42 |
| TAX | 248.18 | 219.62 | 13.00 | 248.18 | 219.62 | 13.00 | 1351.47 | 1078.88 | 25.27 |
| Deferred Tax | -17.42 | -10.30 | 69.13 | -17.42 | -10.30 | 69.13 | -0.08 | -19.91 | -99.60 |
| PAT | 717.46 | 694.85 | 3.25 | 717.46 | 694.85 | 3.25 | 4006.67 | 3193.36 | 25.47 |
| Equity | 247.80 | 242.64 | 2.13 | 247.80 | 242.64 | 2.13 | 247.80 | 242.54 | 2.17 |
| PBIDTM(%) | 18.11 | 19.35 | -6.40 | 18.11 | 19.35 | -6.40 | 22.28 | 19.98 | 11.48 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1942.95 |
| Dr. Reddys Labs. | 1183.00 |
| Cipla | 1415.10 |
| Lupin | 2405.80 |
| Zydus Lifesciences | 1129.75 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: